Cargando…

CCR5 and HIV Infection, a View from Brussels

Detalles Bibliográficos
Autor principal:	Parmentier, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459230/ https://www.ncbi.nlm.nih.gov/pubmed/26106394 http://dx.doi.org/10.3389/fimmu.2015.00295

Ejemplares similares

Maraviroc – A CCR5 Antagonist for the Treatment of HIV-1 Infection
por: Van Der Ryst, Elna
Publicado: (2015)

Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy
por: Mohamed, Hager, et al.
Publicado: (2022)

Editorial: CCR5: A receptor at the center stage in infection
por: Ellwanger, Joel Henrique, et al.
Publicado: (2022)

Localization-Specific Expression of CCR1 and CCR5 by Mast Cell Progenitors
por: Salomonsson, Maya, et al.
Publicado: (2020)

CCR4 and CCR5 Involvement in Monocyte-Derived Macrophage Migration in Neuroinflammation
por: Kim, Jong Youl, et al.
Publicado: (2022)

CCR5 Receptor Occupancy Analysis Reveals Increased Peripheral Blood CCR5+CD4+ T Cells Following Treatment With the Anti-CCR5 Antibody Leronlimab
por: Chang, Xiao L., et al.
Publicado: (2021)

Divergent Expression of CXCR5 and CCR5 on CD4(+) T Cells and the Paradoxical Accumulation of T Follicular Helper Cells during HIV Infection
por: Zaunders, John, et al.
Publicado: (2017)

Short Communication: HIV-1 Variants That Use Mouse CCR5 Reveal Critical Interactions of gp120's V3 Crown with CCR5 Extracellular Loop 1
por: Platt, Emily J., et al.
Publicado: (2015)

Coexpression of CCR7 and CXCR4 During B Cell Development Controls CXCR4 Responsiveness and Bone Marrow Homing
por: Mcheik, Saria, et al.
Publicado: (2019)

Impressions from Brussels
Publicado: (1920)

From Brussels to CERN
Publicado: (1991)

HIV-1 and SIV Predominantly Use CCR5 Expressed on a Precursor Population to Establish Infection in T Follicular Helper Cells
por: Xu, Yin, et al.
Publicado: (2017)

Reduced CCR5 Expression and Immune Quiescence in Black South African HIV-1 Controllers
por: Picton, Anabela C. P., et al.
Publicado: (2021)

The Dual Role of CCR5 in the Course of Influenza Infection: Exploring Treatment Opportunities
por: Ferrero, Maximiliano Ruben, et al.
Publicado: (2022)

The Expanding Therapeutic Perspective of CCR5 Blockade
por: Vangelista, Luca, et al.
Publicado: (2018)

Reunion in Brussels
por: Hines, Earl, 1903-1983
Publicado: (1992)

Unique profile of predominant CCR5-tropic in CRF07_BC HIV-1 infections and discovery of an unusual CXCR4-tropic strain
por: Hu, Xiaoyan, et al.
Publicado: (2022)

CCR5 Inhibitors and HIV-1 Infection
por: Latinovic, Olga S., et al.
Publicado: (2019)

Genetic Polymorphism at CCL5 Is Associated With Protection in Chagas’ Heart Disease: Antagonistic Participation of CCR1(+) and CCR5(+) Cells in Chronic Chagasic Cardiomyopathy
por: Batista, Angelica Martins, et al.
Publicado: (2018)

The Brussels Health Congress
por: Leigh, Gladys M. E.
Publicado: (1920)

Child Welfare at Brussels
Publicado: (1921)

Modernizing Recruitment in Brussels
por: Quitin, Yves, et al.
Publicado: (2011)

Map & guide of Brussels

Natural Proteolytic Processing of Hemofiltrate Cc Chemokine 1 Generates a Potent Cc Chemokine Receptor (Ccr)1 and Ccr5 Agonist with Anti-HIV Properties
por: Detheux, Michel, et al.
Publicado: (2000)

Filling the Gaps in Antagonist CCR5 Binding, a Retrospective and Perspective Analysis
por: Amerzhanova, Yerkezhan, et al.
Publicado: (2022)

Dopamine Levels Induced by Substance Abuse Alter Efficacy of Maraviroc and Expression of CCR5 Conformations on Myeloid Cells: Implications for NeuroHIV
por: Matt, Stephanie M., et al.
Publicado: (2021)

Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy
por: Kwiatkowski, Klaudia, et al.
Publicado: (2020)

Beyond HIV infection: Neglected and varied impacts of CCR5 and CCR5Δ32 on viral diseases
por: Ellwanger, Joel Henrique, et al.
Publicado: (2020)

Revolution in Brussels, 1787-1793 /
por: Polasky, Janet L.
Publicado: (1987)

Annals of the Pathological Society of Brussels
Publicado: (1860)

The International Otological Congress in Brussels
por: Barr, Thomas
Publicado: (1888)

CCR5 Promoter Polymorphisms Associated With Pulmonary Tuberculosis in a Chinese Han Population
por: Liu, Shuyuan, et al.
Publicado: (2021)

Biallelic, Selectable, Knock-in Targeting of CCR5 via CRISPR-Cas9 Mediated Homology Directed Repair Inhibits HIV-1 Replication
por: Scheller, Stefan H., et al.
Publicado: (2022)

Homeless people hospitalized with COVID-19 in Brussels
por: Schrooyen, Loïc, et al.
Publicado: (2021)

CCR1 and CCR5 mediate cancer-induced myelopoiesis and differentiation of myeloid cells in the tumor
por: Zilio, Serena, et al.
Publicado: (2022)

Therapeutic potential of an anti-CCR9 mAb evidenced in xenografts of human CCR9(+) tumors
por: Santamaria, Silvia, et al.
Publicado: (2022)

Natural anti-CCR5 antibodies in HIV-infection and -exposure
por: Lopalco, Lucia
Publicado: (2011)

Accelerated Immunodeficiency by Anti-CCR5 Treatment in HIV Infection
por: Weinberger, Ariel D., et al.
Publicado: (2009)

Targeting CCR5 trafficking to inhibit HIV-1 infection
por: Boncompain, Gaelle, et al.
Publicado: (2019)

The CCR5 Gene Edited CD34(+)CD90(+) Hematopoietic Stem Cell Population Serves as an Optimal Graft Source for HIV Gene Therapy
por: Karuppusamy, Karthik V., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ehhipfjeeipnblk634jsq6g41k